Sarah Kim (S Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Venues

CPT: pharmacometrics & systems pharmacology

Antimicrobial agents and chemotherapy

Clinical and translational science

Journal of pharmacokinetics and pharmacodynamics

University of Florida

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florida

United States

Research Assistant Professor :: Department of Pharmaceutics

Publications

Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool. CPT: pharmacometrics & systems pharmacology (2024)
Deok Yong Yoon, Michael J Daniels, Rebecca J Willcocks, William T Triplett, Juan Francisco Morales, Glenn A Walter, William D Rooney, Krista Vandenborne, Sarah Kim, null null
Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg muscles. Journal of pharmacokinetics and pharmacodynamics (2024)
Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Deok Yong Yoon, Michael J Daniels, Rebecca J Willcocks, William T Triplett, Juan Francisco Morales, Glenn A Walter, William D Rooney, Krista Vandenborne, Sarah Kim, null null
Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg muscles. Journal of pharmacokinetics and pharmacodynamics (2024)
Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Jackson Burton, Bilal Abuasal, Sagar Bachhav, Jamie Connarn, Josh Cosman, Neeraj Gupta, Jing Jing, Sarah Kim, Tao Long, Nadia Terranova, Karthik Venkatakrishnan, Jian Wang, Qi Liu
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision. Clinical pharmacology and therapeutics (2023)
David B Jackson, Rebecca Racz, Sarah Kim, Stephan Brock, Keith Burkhart
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD 3 ). Pharmaceutics 15 (6) (2023)
Juan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, Jackson Burton, Sarah David, Patrick Lang, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies. CPT: pharmacometrics & systems pharmacology (2023)
Mohammed Almoslem, Sanket D Shah, Valvanera Vozmediano, Serge Guzy, Sarah Kim, Mark L Hudak, Stephan Schmidt
Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates Less Than 29 Weeks' Gestation. Journal of clinical pharmacology (2023)
Stephan Schmidt, Valvanera Vozmediano, Rodrigo Cristofoletti, Sarah Kim, Zhoumeng Lin, Natalia Valadares De Moraes, Francine Azeredo, Brian Cicali, Hans Leuenberger, Joshua D Brown, Jin Yan Jin, Cynthia J Musante, Stacey Tannenbaum, Yaning Wang
Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians. CPT: pharmacometrics & systems pharmacology 12 (7) (2023)
Juan Francisco Morales, Rhoda Muse, Jagdeep T Podichetty, Jackson Burton, Sarah David, Patrick Lang, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies. CPT: pharmacometrics & systems pharmacology (2023)
Sarah Kim, Rebecca J Willcocks, Michael J Daniels, Juan Francisco Morales, Deok Yong Yoon, William T Triplett, Alison M Barnard, Daniela J Conrado, Varun Aggarwal, Ramona Belfiore-Oshan, Terina N Martinez, Glenn A Walter, William D Rooney, Krista Vandenborne
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials. CPT: pharmacometrics & systems pharmacology (2023)
Rebecca J Willcocks, Alison M Barnard, Michael J Daniels, Sean C Forbes, William T Triplett, John F Brandsema, Erika L Finanger, William D Rooney, Sarah Kim, Dah-Jyuu Wang, Donovan J Lott, Claudia R Senesac, Glenn A Walter, H Lee Sweeney, Krista Vandenborne
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy. Annals of clinical and translational neurology (2023)
Juan Francisco Morales, Rhoda Muse, Jagdeep Podichetty, Jackson Burton, Sarah David, Patrick Lang, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell-Thompson, Michael J Haller, Mark A Atkinson, Sarah Kim
Disease Progression Joint Model Predicts Time to Type 1 Diabetes Onset: Optimizing Future Type 1 Diabetes Prevention Studies. CPT: pharmacometrics & systems pharmacology (2023)
David B Jackson, Rebecca Racz, Sarah Kim, Stephan Brock, Keith Burkhart
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD 3 ). Pharmaceutics 15 (6) (2023)
Walter M Yamada, Sarah Kim, Mohammed Almoslem, Soyoung Kim, Jenny Myrick, Jocelyn Nole, Brandon Duncanson, Arnold Louie, Charles A Peloquin, Stephan Schmidt, George L Drusano, Michael Noel Neely
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype. Antimicrobial agents and chemotherapy 66 (10) (2022)
Sarah Kim, Gezim Lahu, Majid Vakilynejad, Theodoros G Soldatos, David B Jackson, Lawrence J Lesko, Mirjam N Trame
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors. Clinical and translational science 15 (6) (2022)
Scott A Mosley, Sarah Kim, Nihal El Rouby, Karthik Lingineni, Valvanera Vozmediano Esteban, Yan Gong, Yiqing Chen, David Estores, Kairui Feng, Hyewon Kim, Minori Kinjo, Taimour Langaee, Zhichuan Li, Siegfried O F Schmidt, Julie A Johnson, Reginald F Frye, Lanyan Lucy Fang, Liang Zhao, Philip F Binkley, Stephan Schmidt, Larisa H Cavallari
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. Clinical and translational science 15 (7) (2022)
Theodoros G Soldatos, Sarah Kim, Stephan Schmidt, Lawrence J Lesko, David B Jackson
Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports. CPT: pharmacometrics & systems pharmacology 11 (5) (2022)
Sarah Kim, Gezim Lahu, Majid Vakilynejad, Theodoros G Soldatos, David B Jackson, Lawrence J Lesko, Mirjam N Trame
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development. Clinical and translational science 15 (4) (2022)
George L Drusano, Sarah Kim, Mohammed Almoslem, Stephan Schmidt, D Z D'Argenio, Jenny Myrick, Brandon Duncanson, Jocelyn Nole, David Brown, Charles A Peloquin, Michael Neely, Walter Yamada, Arnold Louie
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens. Antimicrobial agents and chemotherapy 65 (2) (2021)
George L Drusano, Stephanie Rogers, David Brown, Charles A Peloquin, Michael Neely, Walter Yamada, Sarah Kim, Mohammed Almoslem, Stephan Schmidt, Arnold Louie
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression. Antimicrobial agents and chemotherapy 65 (4) (2021)
Unai Caballero, Sarah Kim, Elena Eraso, Guillermo Quindós, Valvanera Vozmediano, Stephan Schmidt, Nerea Jauregizar
In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris. Antibiotics (Basel, Switzerland) 10 (4) (2021)
Sarah Kim, Walter M Yamada, Brandon Duncanson, Jocelyn Nole, Stephanie Rogers, Sarah Parker, Meredith Bacci, Nino Mtchedlidze, Charles A Peloquin, Arnold Louie, Stephan Schmidt, George L Drusano, Michael Noel Neely
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase. Antimicrobial agents and chemotherapy 65 (10) (2021)
Ching-Yu Wang, Phuong N Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua D Brown
Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States. Clinical and translational science 13 (2) (2020)
G L Drusano, Michael N Neely, Sarah Kim, Walter M Yamada, Stephan Schmidt, Brandon Duncanson, Jocelyn Nole, Nino Mtchedlidze, Charles A Peloquin, Arnold Louie
Building Optimal Three-Drug Combination Chemotherapy Regimens. Antimicrobial agents and chemotherapy 64 (11) (2020)
Alan Talevi, Juan Francisco Morales, Gregory Hather, Jagdeep T Podichetty, Sarah Kim, Peter C Bloomingdale, Samuel Kim, Jackson Burton, Joshua D Brown, Almut G Winterstein, Stephan Schmidt, Jensen Kael White, Daniela J Conrado
Machine Learning in Drug Discovery and Development Part 1: A Primer. CPT: pharmacometrics & systems pharmacology 9 (3) (2020)
George L Drusano, Brandon Duncanson, C A Scanga, Sarah Kim, S Schmidt, M N Neely, W M Yamada, Michael Vicchiarelli, Charles A Peloquin, Arnold Louie
Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models? Antimicrobial agents and chemotherapy 64 (12) (2020)

Sarah Kim.css-eqlu8i{font-size:small;padding-left:4px;} (S Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah Kim (S Kim)